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Abstract
Background: Mutarotases are recently characterized family of enzymes that are involved in the anomeric conversions 
of monosaccharides. The mammalian fucose mutarotase (FucM) was reported in cultured cells to facilitate fucose 
utilization and incorporation into protein by glycosylation. However, the role of this enzyme in animal has not been 
elucidated.
Results: We generated a mutant mouse specifically lacking the fucose mutarotase (FucM) gene. The FucM knockout 
mice displayed an abnormal sexual receptivity with a drastic reduction in lordosis score, although the animals were 
fertile due to a rare and forced intromission by a typical male. We examined the anteroventral periventricular nucleus 
(AVPv) of the preoptic region in brain and found that the mutant females showed a reduction in tyrosine hydoxylase 
positive neurons compared to that of a normal female. Furthermore, the mutant females exhibited a masculine 
behavior, such as mounting to a normal female partner as well as showing a preference to female urine. We found a 
reduction of fucosylated serum alpha-fetoprotein (AFP) in a mutant embryo relative to that of a wild-type embryo.
Conclusions: The observation that FucM-/- female mouse exhibits a phenotypic similarity to a wild-type male in terms 
of its sexual behavior appears to be due to the neurodevelopmental changes in preoptic area of mutant brain 
resembling a wild-type male. Since the previous studies indicate that AFP plays a role in titrating estradiol that are 
required to consolidate sexual preference of female mice, we speculate that the reduced level of AFP in FucM-/- mouse, 
presumably resulting from the reduced fucosylation, is responsible for the male-like sexual behavior observed in the 
FucM knock-out mouse.
Background
Fucose mutarotase (FucM) is an enzyme that is involved
in the anomeric conversion of L-fucose [1] in the salvage
pathway for GDP-fucose synthesis, which facilitates the
incorporation of L-fucose into protein. The importance
of fucosylation has been exemplified by the case of
human congenital disorders of glycosylation (CDGs).
CDGs, classified as CDG types I and II, involve an
impaired glycosylation with complex pathologies of
developmental alteration in the brain, liver, and immune
system. CDG-IIc results from a defect in GDP-L-fucose
transport into Golgi [2-4]. GDP-L-fucose is formed either
by the de novo or salvage pathways, which in Golgi serves
as a substrate for the glycosylation mediated by different
fucosyltransferases. Mice deficient in FX, an enzyme syn-
thesizing GDP-fucose from GDP-mannose as part of the
de novo pathway, exhibit embryonic lethality, premature
death, or infertility due to the deficiency of cellular fuco-
sylation [5]. Interestingly, this phenotype can be rescued
by a fucose supplement.
The sexual differences in mice are characterized by
their reproductive behaviors, e.g. mounting or receptiv-
ity. Feminization in sexual dimorphism is believed to be a
default state that leads to a neural substrate conducive to
female reproductive behavior [6]. The loss of female-like
characteristics can be assessed by examining tyrosine
hydroxylase expression in the anteroventricular nucleus
of the preoptic region (AVPv) [7-9] as a sexually dimor-
phic marker. According to the classical view, sexual dif-
ferentiation in the brain occurs under the influence of
testosterone and/or estradiol derived from neural aroma-
tization of testosterone: the brain develops as male in the
presence of these steroid hormones, and as female in
their absence. Consistently, recent studies suggest that
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the estrogen produced by the placenta during late gesta-
tion can affect sexual differentiation into female unless it
is not titrated by alpha-fetoprotein (AFP) that has an
affinity to estrogen [10-13]. The role of AFP in the devel-
opment of the female brain has been demonstrated by an
observation in which knockout mice lacking alpha-feto-
protein were infertile [14] due to an impairment of the
hypothalamic/pituitary system and to a failure in the
estrous cycle [14,15]. The consequence was a complete
absence of ovulation in the homozygous Afp-knockout
mouse [14] and a behavioral change among the females
that was indicative of defeminization [9]. AFPs contain
carbohydrate moieties and thus exist in heterogeneous
isoforms, whose synthesis decreases dramatically after
birth with trace amounts of expression in the adult liver.
Human AFP contains a single N-linked glycan, whereas
murine AFP has two N- and one O-glycans [16]. Estradiol
binding was only reported for murine AFP [17-19].
I n  t h i s  s t u d y ,  w e  g e n e r a t e d  m u t a n t  m i c e  s p e c i f i c a l l y
lacking the FucM gene that encodes fucose mutarotase.
The homo- and heterozygous mutant females exhibited
deficits in sexual receptivity as demonstrated by a drop in
lordosis score. Moreover, the mutants displayed mascu-
line behaviors and preferences to female urine over male
urine. The possible association of such behavioral change
with an altered level of alpha-fetoproteins in FucM-/- mice
is discussed.
Results
FucM-/- results in a change in female sexual receptivity
We generated FucM-/- (KO) mice by replacing exons 2, 3,
and 4 of the fucose mutarotase gene (FucM) with a puro-
mycin resistance gene using embryonic stem (ES) cells
derived from a 129x1/SvJ mouse (Figure 1A). The correct
gene targeting was confirmed by Southern blotting (Fig-
ure 1B) and also by PCR (Figure 1C) with the primer sets
used to detect the wild-type (primer 1 and 2) and knock-
out alleles (primer 3 and 4). FucM-targeted clones were
injected into C57BL/6 recipient blastocysts, and the
obtained chimeras were crossed with C57BL/6 partners.
The heterozygous mice for the FucM allele (FucM+/-, HZ)
were crossed to generate homozygous FucM-/- mice. The
hetero- and homozygous knockout animals did not show
any indication of embryonic lethality with statistically
significant Mendelian segregation ratios. The most
apparent abnormality was a mutant female avoiding a
normal male partner in the regular mating cage, while a
slight loss in body weight and minor behavioral change
were occasionally observed for the hetero- or homozy-
gous mutant animals (data not shown). Thus, we system-
atically analyzed the reproductive behaviors of FucM
mutant mice.
Mutant female suppresses lordosis, with occasional mating 
by forced intromission
For testing the female-typical sexual behavior of FucM
mutants, we observed both gonad-intact and ovariecto-
mized (OVX) females. The gonad intact females were
assessed for their stages of estrous cycle using vaginal
smears in order to select individuals (n = 13) at the estrus
stage. The wild types (WTs) and FucM mutants did not
exhibit any difference in hormonal cycle. The ovariecto-
mized females (WT, n = 15; HZ and KO, n = 16) were
subcutaneously implanted with an osmotic mini-pump in
order to infuse them with 17β-estradiol (E2) in sesame oil,
and were tested three times on a week interval. For the
third trial, the mice were injected with 500 μg of proges-
terone four hours before the tests. Female sexual recep-
tivity was measured by calculating the lordosis quotient
(multiplied by 100) as the number of times a female
exhibited lordosis divided by the number of mounts.
There were no genotype differences in the total number
of social contact behaviors such as sniffing, chasing, or
touching of the bodies of the females by a wild-type stud
male. However, in the sexual behaviors of the stud males,
such as attempted mounts, mounts, and intromissions,
clear differences were found between genotypes, particu-
larly because of rejection by females. About 59, 11, and
5% of the WT, HZ, and KO gonad-intact females, respec-
tively, showed sexual receptivity at least once during a 20
min test period (Figure 2A).
One-way ANOVA with genotype as the independent
factor indicates the significance of differences between
genotypes [F(2,36) = 137.68, P < 0.001]. The receptivity of
the KO females was comparable with that of HZs (P >
0.05), but significantly lower than that of the WTs (P <
0.001) by a post-hoc Fisher probable least-squares differ-
ence (PLSD) comparison. The change in sexual receptiv-
ity, i.e. reduced lordosis, observed in the FucM mutants
was further verified for ovariectomized females with a
treatment of sexual hormone (E2). The ovariectomized
HZ and KO females displayed sexual receptivity lower
than that of the WTs in response to a male suitor (Figure
2A). Repeated measures ANOVA indicate that there is a
significant effect of genotype on lordosis quotients
[F(2,44) = 166.57, P  < 0.001] and on repeated testing
[F(2,88) = 25.87, P < 0.001], as well as on the interaction
between these factors [F(4,88) = 4.41, P  < 0.001].
Although the mean lordosis quotients in ovariectomized
KO females were slowly increased with time, they were
significantly lower than that of the wild-type females in
all trials. Interestingly, the HZ females displayed an inter-
mediate lordosis response, which was significantly differ-
ent from that of the WTs and KOs by the post-hoc
comparisons (P < 0.001 compared to the WTs or KOs),Park et al. BMC Genetics 2010, 11:62
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Figure 1 Targeted Disruption of the FucM Gene. (A) Schematic diagram for the targeted disruption of the FucM gene. The structures of the target-
ing vector, wild-type, and disrupted FucM alleles are shown. The solid boxes represent the exons (a total of six in the wild-type). The restriction sites 
used for constructing the targeting vector and for analysis by Southern blot are EcoRV, BssHI, ScaI, and KpnI. A puromycin expressing cassette was 
inserted between the EcoRV and ScaI sites, eliminating exons 2-4 and the EcoRV site of the WT gene. (B) Southern analysis for genomic DNA from the 
wild-type (+/+), heterozygous (+/-) and FucM null (-/-) mice. The expected sizes of the wild-type and disrupted FucM alleles are 10 and 16 Kb, respec-
tively, which were detected by Southern blotting with EcoRV digestion and hybridization using the probe 1 shown in (A). (C) The wild-type (primer 1 
and 2) and disrupted alleles (primer 3 and 4) were also detected by PCR.Park et al. BMC Genetics 2010, 11:62
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Figure 2 Sexual behaviors of wild-type and FucM knockout females. (A) Lordosis quotients of gonads-intact (left) and ovariectomized females 
(right). Lordotic responses by three consecutive tests were observed for the ovariectomized wild-type controls and FucM gene-disrupted mice after 
treatments with E2 (test 1 and 2) and E2 plus progesterone (test 3). The tests were carried out at a one-week interval. The scores of the KO females were 
different with P < 0.001 (*) from that of the wild-type and P > 0.05 (#) from that of heterozygote. (B) Frequencies of attempted mounts, mounts and 
intromission-like behaviors in three consecutive tests of subject females with a female partner. (C) Photomicrographs of sections in AVPv stained by 
immunohistochemistry for tyrosine hydroxylase in males, wild-type females, and FucM KO females. (D) Numbers of tyrosine hydroxylase-immunore-
active (ir) neurons in the sections shown in C: *, P < 0.001 compared to that of the wild-type males; #, P < 0.001 compared to that of wild-type females. 
Data are shown as mean ± s.e.m.Park et al. BMC Genetics 2010, 11:62
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l i k e l y  r e f l e c t i n g  a  d o s e - d e p e n d e n t  e f f e c t  o f  f u c o s e
mutarotase on behavior.
Male-typical coital behavior displayed by the mutant mice
The lack of female receptivity in FucM mutants further
led us to test whether the KO females exert male-typical
sexual behavior, which was examined over three weeks by
placing an E2-stimulated female partner of WT into the
home cage of an ovariectomized female (WT, n = 13; HZ,
n = 12; KO, n = 10). The mutant female mice showed
masculine behaviors, such as attempted mounting,
mounting, and pseudo-intromission, towards an estra-
diol-primed partner female (Figure 2B). The male-typical
behaviors were scored for 30 min. For the third trial, the
ovariectomized females were injected with 500 μg of pro-
gesterone. Repeated measures ANOVA indicated that the
frequencies of attempted mounts and actual mounts of
female partners by tested females were significantly
higher than that of the control females [F(2,32) = 15.03, P
< 0.001], and there was a significant effect of repeated
testing [F(2,64) = 16.49, P < 0.001] as well as a significant
factor interaction [F(4,64) = 6.15, P < 0.001]. Differences
between groups were obtained by Fisher's post hoc analy-
sis, in which the KO females can be compared to the WT
and HZ females (P < 0.001) with significance. Unlike the
lordosis behavior, the male-typical coital behavior of the
mutant females were notably reduced by the hormone
(E2) treatment.
Reduced tyrosine hydroxylase expression in the FucM 
mutant
The populations of tyrosine hydroxylase (TH)-expressing
hypothalamic cells are sexually dimorphic in rats and
mice [20,21]. TH-immunoreactive (ir) positive neurons in
the anteroventral periventricular nucleus (AVPv) of the
preoptic region regulating gonadotropin release are nec-
essary for female ovulation, whose numbers in a female,
in addition to their size difference, are two to four times
greater than in a male [7,20-22]. Ovariectomy of the
female does not affect TH expression, while chronic
treatment with high levels of estradiol reduces its expres-
sion [7,20]. When we examined the tyrosine hydroxylase
positive neurons in the AVPv in the control and mutant
mice by immunohistochemistry, the FucM  KO female
mice exhibited less TH-immunoreactive cells in the AVPv
than the normal female mice, albeit slightly more than
those of the normal males (Figure 2C and 2D). One-way
ANOVA indicates significant differences between the
groups [F(2,30) = 18.57, P < 0.001]. The apparent lack of
knock out phenotype in male mouse seems to be consis-
tent with an indistinguishable pattern of TH-ir neurons
in the mutant male from that of wild-type male in the
AVPv region of the brain (data not shown).
FucM mutant female prefers female urine
The key to gender-specific behavior in mice is a cluster of
receptors in their noses, which allows them to smell pher-
omones, eliciting a sexual signal among members of the
same species. Male and female mice are motivated to
approach the opposite sex by specific responses to uri-
nary odors [23]. We investigated the olfactory respon-
siveness of the FucM  mutant to the urinary odors of
estrous females. The urine preference tests were carried
out with simultaneous presentation of male and female
urine. The time that the subject mice spent sniffing male
or female urine through nasal contact was scored for 5
min. Preference of the WT females for male urine were
noted, while the WT males and KO females preferred
female urine (Figure 3). ANOVA of the preference for
female urine indicated a significant effect of genotype
[F(2,39) = 47.24, P < 0.001], with significant results of
Fisher's post-hoc analysis for the KO females compared to
the WT males and females (P < 0.001). Also, ANOVA of
the preference for male urine indicated a significant effect
of genotype [F(2,39) = 42.15, P < 0.001]. Destruction of
olfactory epithelium by ZnSO4 eliminated any sniffing of
stimulating urine (data not shown).
Deficiency in fucose mutarotase reduces serum level of 
fucosylated alpha-fetoprotein
From the male-like behavioral change of FucM mutant
females and the corresponding alterations in the neural
substrate, one can imagine that a change in sexual differ-
entiation is responsible for the phenotypic difference.
One likely candidate eliciting such change is alpha-feto-
Figure 3 The olfactory response of female mice lacking FucM. The 
mean time spent sniffing male and female urine by wild-type males (n 
= 15), wild-type females (intact, n = 15; OVX, n = 13) and FucM KO fe-
males (intact, n = 12; OVX, n = 10). Result of post-hoc comparisons by 
the Fisher PLSD test are indicated as follows: *, P < 0.001 when com-
pared to wild-type males for male urine; #, P < 0.001 when compared 
to wild-type males for female urine. Data are expressed as mean ± 
s.e.m.Park et al. BMC Genetics 2010, 11:62
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protein, recently implicated in mediating a hormonal
effect on brain development [9,15] associated with sexual
behavior, during the late gestation to birth. Since fucose
mutarotase affects the intracellular level of GDP-fucose,
and thus fucosylation, an immediate consequence of a
FucM defect would be a change, i.e. reduction, in AFP
fucosylation. We investigated the fucosylation status of
whole protein and serum protein, focusing on AFP, dur-
ing embryogenesis using two-dimensional electrophore-
sis and a MALDI-MS analysis of proteins from an embryo
at 16.5d postcoitum (dpc), indicating that AFPs are a
major group of proteins being expressed during gestation
in both WT and KO mice.
When we monitored gene expression levels of AFP by
real-time PCR in KO and WT, there was no significant
difference between WT (n = 3) and KO (n = 3) embryos
( F i g u r e  4 A ) .  H o w e v e r ,  t h e  a b s o l u t e  l e v e l s  o f  A F P s  a r e
lower in a KO embryo (Figure 4B), presumably reflecting
an inefficient secretion into the serum [24] or a problem
with turnover. We further analyzed amounts and fucosy-
lations of the AFP isoforms by separating on 2D gel elec-
trophoresis (Figure 4C). The total amounts of
Coomassie-stained proteins are higher in WT than that
of KO, which is consistent with the data in Figure 4B.
When we assessed fucosylations in different AFP iso-
forms by blotting with the AAL and UEA-I lections, rec-
ognizing α-1,6/α-1,3 and α-1,2 linkages, respectively, the
signals are generally lower in the KO embryo compared
to that of wild type, although there are variations in dif-
ferent isoforms. Since the fucosylation signals were stan-
dardized by the amounts of Coummassie-stained
proteins, this reduction indeed indicates overall decrease
in AFP fucosylation.
Embryonic levels, not affinity, of AFPs are responsible for 
estradiol titration
In order to test whether the different amounts of fucosy-
lated AFP correlate with estradiol bindings, a serum con-
centration of AFP was calculated by 2D-western blotting,
and the affinity constants for E2 of the serum was investi-
gated using saturation analysis in 16.5 dpc embryos (Fig-
ure 4D). The equilibrium association constant (Ka) and
maximal binding capacity (Bmax) were estimated by
Scatchard plotting. Blood from each embryo was taken
by heart puncture, from which the same volumes of sera
after removing the blood cells were used to determine the
binding activities for E2 and for western analysis. In fetal
mouse serum, AFP and albumin are the major proteins,
among which only AFP exerts an E2 binding activity [18].
Because the binding activity of AFP for E2 depends on
conditions [18,25] such as carbohydrate modifications,
embryonic stage (15-18 days of gestation) and purifica-
tion methods, crude serum samples were used for moni-
toring the in vivo states affecting brain development.
As shown in Figure 4D, the Ka values for E2 in crude
embryonic sera were similar (WT; ~0.24 × 107 M-1 and
KO; ~0.23 × 107 M-1), although the Bmax for E2 in the con-
trols differs from that of the mutants. The differences in
Bmax for E2, but not in Ka, appear to reflect the differences
in the amount of AFPs (Figure 4B, 4C) present in the sera.
Discussion
We investigated the role of fucose mutarotase by generat-
ing mice in which the FucM gene was selectively ablated.
The mutant mice were healthy without any indication of
anatomical abnormalities. The most distinct phenotype
observed with the mutant female mice was a significant
reduction in hormone-stimulated sexual receptivity mea-
sured as a lordosis quotient. Although the homozygous
mutant females exhibited altered sexual behaviors, i.e.
reduced lordosis and male-typical coital behavior, they
were fertile with typical estrous cycles and ovulation,
similar to that of a normal female. Most of the mutant
females became pregnant, and an average of 8.6 pups was
produced per litter. The successful mating of the KO
females was probably due to the forced mating attempts
of sexually experienced males despite rejections by the
females. We did not observe differences in maternal
behavior between WT and KO females (data not shown).
Proceptivity behaviors such as solicitation were also
avoided by the KO females (data not shown). In the case
of AFP knockout mouse, the female exhibits a defect in
ovulation, in addition to a change in sexual preference of
female [9]. A sole alteration of behavioral phenotype in
FucM  knockout mutant, while preserving its fertility,
might lie in different degrees of estrogen titration by AFP,
i.e. lack of AFP versus the reduced level of fucosylated
AFP, during embryonic development for sexual dimor-
phism. Although the knockouts of estrogen receptors,
ERα and ERβ, show either one or both of the phenotypes,
abnormal sexual receptivity and fertility [26,27], the
mechanism underlying these alterations might be differ-
ent due to its postnatal nature of manifestation. The
behavioral abnormality in female knock-out mouse was
observed in the progenies with the mixed genetic back-
ground made between the 129sv and C57BL/6 inbred
lines as usually did in most knock out studies. Thus, it
would be desirable in later investigation to observe a phe-
notypic persistence in homogeneous genetic background
after a series of inbreeding as demonstrated previously in
the experiment with AFP knock-out mouse [9].
Since a FucM-/- female mouse exhibits a phenotypic
similarity to a wild-type male in terms of its sexual behav-
ior, we speculated that the reproductive circuitry of the
mutants might have altered to resemble that of a wild-Park et al. BMC Genetics 2010, 11:62
http://www.biomedcentral.com/1471-2156/11/62
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Figure 4 Amounts of AFP and its binding to 17β-estradiol in embryonic sera. (A) Gene expression analysis of AFP in WT and KO embryos at E16.5. 
The amplified copies of AFP were normalized against GAPDH, from which the ratio between copy numbers was determined to obtain normalized fold 
change. (B) Fetal mouse sera containing AFP (arrow) were visualized by 10% SDS-PAGE, followed by Coomassie brilliant blue (CBB) staining, which 
were obtained from 25 each of wild-type and mutant embryos at E16.5. They were diluted 1/30 and loaded. (C) Embryonic serum proteins from the 
WT and the FucM deficient mice were subjected to 2-D electrophoresis, followed by CBB staining. After blotting onto a nitrocellulose membrane, lectin 
blotting was performed. Aleuria aurantia lectin (AAL) binds to N-linked oligosaccharides with L-fucose linked (α-1,3/α-1,6) to the proximal GlcNAc res-
idue, while Ulex europaeus agglutinin I preferentially binds to Fucα(1-2)Galβ(1-4)GlcNAc. Spot intensities were analyzed using ImageJ to estimate rel-
ative fucosylation levels of AFP. (D) Scatchard analyses for the interactions of 17β-estradiol (E2) with mouse embryonic sera are shown, which were 
determined by the dextran-coated charcoal (DCC) technique as described in the Methods section.Park et al. BMC Genetics 2010, 11:62
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type male mouse. Since the circuitry starts from sensing a
pheromonal cue in olfactory system [28,29], we carried
out a urine preference test to investigate the abnormality
in the mutants. The time spent by KO females sniffing
female urine was comparable to that of the WT males,
which was significantly longer than that of male urine
(Figure 3). Since the olfactory partner preference is sexu-
ally dimorphic and organized by perinatal exposure to
gonadal steroids [30], it is possible that the brain of FucM-
/- females might have experienced a male-like sexual dif-
ferentiation during development. The sexual differentia-
tion of the female brain occurs during a critical period of
development, in which sexually dimorphic neural popu-
lations are organized by testosterone or its metabolite
estradiol [6]. The AVPv of the hypothalamus is sexually
dimorphic and the neurons that express tyrosine hydrox-
ylase (TH) are more abundant in that of the female [31].
When we analyzed the sexually dimorphic populations of
tyrosine hydroxylase (TH)-immunoreactive neurons in
the AVPv nuclei of FucM-/- and wild-type littermates, an
alteration in the forebrain system of the FucM-/- females
was observed, i.e. a lower number of TH-positive neurons
as in the wild-type males.
Feminization is known to be induced by blocking estro-
gen action during embryonic development, which is
achieved by an alpha-fetoprotein binding to circulating
estradiol in the female fetus [9,32]. However, defeminiza-
tion can occur by an increased level of estradiol [6,33,34],
and perhaps masculinization by affecting cyclooxyge-
nase-2 (COX-2) regulation to increase prostaglandin E2
(PGE2) [35]. In our study, an altered level of fucosylated
alpha-fetoproteins was detected in the FucM-/-  mice,
which was analyzed by 2D gel electrophoresis and lectin
blotting for fucosylated proteins, followed by MALDI-
TOF MASS fingerprinting (Figure 4C). Thus, it is tempt-
ing to speculate that the altered level of serum alpha-feto-
protein might be responsible for sexual abnormality in
the FucM KO mice. Since the level of fucose mutarotase
is reported to affect the intracellular level of GDP-fucose,
and thus fucosylated proteins [1], the altered level of AFP
is very likely to result from different fucosylations.
The AFP isofoms we detected are similar to that
reported previously in hepatocellular carcinoma (HCC)
and nonseminomatous germ cell tumors (NSGCTs)
patients [36]. We observed that fucosylations of AFP iso-
forms were lower in FucM KO mouse than that of WT
m o u s e ,  a l t h o u g h  s o m e  A F P  i s o f o r m s  w e r e  e s s e n t i a l l y
unchanged (Figure 4C). Since protein containing glycans
with more sialic acids (SAs) have lower pI and higher
molecular mass, the AFP spots are displayed as a
descending row on two-demensional gel. Differences in
lectin signal by AAL and UEA-I in WT and KO AFP iso-
forms might be explained by altered fucosylation effi-
ciency due to differences in their glycan structures.
Although there is no direct evidence on the effect of fuco-
sylation on either secretion or stability of AFP, it is likely
to happen in vivo based on previous results where the
folding and stability of proteins were modulated by other
types of glycosylations [24,37,38]. For example, fucosyla-
tion and further elongation of saccharide are critical for
the activity of Notch [39,40]. The fucosylation of glyco-
proteins, including α1-antitrypsin (AAT), hepatoglobin
(Hp), and α1-acid glycoprotein (AGP), may facilitate their
secretion into bile ducts in the liver through an apical sur-
face of human hepatocytes [41]. Also, fucosylation of syn-
apsin critically affects its expression and turnover in
presynaptic nerve terminals [42].
The maximal level of AFP in a human fetus is about 3
mg/ml, which decreases to a basal level of approximately
2-20 ng/ml in an adult [43]. However, this level went up
to 342 ng/ml in patients with hepatocellular carcinoma
[44]. In adult mice, the basal level of AFP is somewhat
higher than in human sera, and is variable in different
inbred lines. BALB/c/J mice have 994 ng/ml concentra-
tions of AFP on average, while other strains have between
34 and 173 ng/ml [45]. In our estimation, the AFP con-
centration of a wild-type embryo was about 5.1 mg/ml,
whereas it decreased to about 23.5% in a FucM-/- KO
embryo. Since the total amount of serum estradiol in 18d
embryonic mice is about 90 pg/ml with free estradiol of
less than 1 pg/ml [46], presumably being regulated by the
amount of AFP [32], the observed difference in the
amounts of AFP in embryonic sera might be critical in
titrating estradiol associated with defeminization. In our
study, the level of AFP in serum was decreased in FucM-
deficient embryo, although change in the levels of hepatic
AFP was not observed (data not shown), reflecting the
difference in Bmax for E2, not on the binding affinity (Ka).
This may imply that the fucosylation of AFP may not be a
signal for its secretion into the serum. Alternatively, the
carbohydrate portion of AFP might be involved in modu-
lating the serum concentration of AFP as in the case of
the desialylated mouse AFP that binds to the asialopro-
tein receptors, which is subject to be endocytosed and
degraded [47].
Conclusions
The study demonstrates that FucM-/-  female mouse
exhibits a phenotypic similarity to a wild-type male in
terms of its sexual behavior. We speculate that this behav-
ioural change is likely to be related to the neurodevelop-
mental change in preoptic area of mutant brain that
became similar to that of wild-type male. Since the level
of AFP, playing a role in titrating estradiol, is known to
affect development of female brain associated with sexual
preference, we speculate that the lower level of AFP, pre-Park et al. BMC Genetics 2010, 11:62
http://www.biomedcentral.com/1471-2156/11/62
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sumably resulting from the reduced fucosylation, in the
mutant embryo causes abnormal brain development. Our
studies on the FucM-/- mouse may provide an animal
model for understanding sexual preference of animal at
genetic as well as epigenetic levels.
Methods
Targeted deletion of FucM gene and the generation of 
mutant mice
The murine FucM gene (LOC69064) was isolated from a
129x1/SvJ genomic BAC (bacterial artificial chromo-
some) library (Research Genetics). A PGK-puro expres-
sion cassette, including the puro gene being transcribed
by the mouse phosphoglycerate kinase (PGK) promoter
with the PGK poly(A) addition site, was obtained from
the pBluescript II KS (+). An approximately 5.1 kb BssHI/
EcoRV genomic fragment upstream of the exon 2, and an
approximately 4.8 kb ScaI/KpnI genomic fragment of the
FucM gene including the exons 5 and 6, as shown in Fig-
ure 1A, were filled in by Klenow polymerase. To generate
a targeting construct, the genomic fragments were sub-
cloned into the puro expression cassette of the PGK-puro
target vector. A diphtheria toxin A (DTA) cassette for
negative selection was flanked to the 3' end of the FucM
sequences by cloning into the NotI site. The vector was
linearized with SalI digestion prior to electroporation.
E14K embryonic stem (ES) cells, derived from 129x1/SvJ
mice, were cultured on mouse embryo fibroblast feeder
cells that are mitotically inactive and puromycin-resis-
tant. The cells were electroporated with a linearized tar-
geting vector and screened for homologous
recombination by Southern blot hybridization using the
5' flanking probe 1 shown in Figure 1A. Two targeted
clones were detected out of the 340 clones screened. A
targeted ES clone was injected into C57BL/6 blastocysts
to generate chimeras. The chimeras were tested for ger-
mline transmission of the ES cell by mating with C57BL/6
mice; offspring with an agouti coat color must have been
derived from the targeted ES cells, indicating germline
transmission. The heterozygous mice were interbred to
obtain mice homozygous for the disrupted FucM gene.
Animals
The FucM KO mice and their WT and HZ littermates
from a mixed background of C57BL/6 and 129x1/SvJ
were used. The mice were housed in a specific pathogen-
free (SPF) facility operating in a controlled air-filtered
environment with autoclaved water, cages, and bedding,
and were fed sterilized Purina rodent chow. All of the
mice were raised in Space Saver' cages (Model 1145T,
Tecniplast, Buguggiate, Italy) in temperature-controlled
facilities at 22°C under 12 h of a light-dark cycle with the
light on at 07:00. Humidity was maintained at 55% with
food and water freely available. All manipulations of the
mice were performed in accordance with NIH guide lines
for the Care and Use of Laboratory Animals.
Test for sexual receptivity
A l l  m a l e  a n d  f e m a l e  m i c e  w e r e  h o u s e d  w i t h  p a r e n t s
before weaning (25 days). The female subjects were
housed together prior to ovariectomy. The ovariecto-
mized female mice were housed individually prior to
behavior experiments. The female mice at the ages of 10-
12 weeks were used to test feminine sexual behavior and
male coital behavior. All experiments began 1 hr after the
start of dark cycle (7 pm) in a Space Saver' cages (Width
30 cm × Depth 13 cm × Height 20 cm) in SPF facility. As a
preliminary step for sexual receptivity tests, the stud
males, chosen by screening sexually vigorous male mice,
were placed in the presence of a 17β-estradiol (Calbio-
chem) primed female in an adjacent chamber, in order for
an exposure to visual, auditory, and olfactory cues with-
out any physical contact [48]. Males were allowed to
habituate in their new environment for at least 15 min
prior to the start of the test. Gonad-intact females were
selected at the estrus stage using vaginal smear and
Papanicolaou (PAP) staining [49]. In adulthood, stimulus
females were ovariectomized using Avertin Anesthesia
and received an Alzet mini-osmotic pump (model 2004,
Durect Corp., Cupertino, CA, USA) containing 1.6 μg/μl
of 17β-estradiol (E2) for a continuous infusion [50]. The
pump flux was 0.25 μl/h and the infusion was continued
for 3 weeks from the start of the experiment. In the third
trial, they were tested 4 h after injection with 500 μg pro-
gesterone (Calbiochem) [9,50,51]. In each test, lordosis
behavior of the female was recorded for 20 min for the
m o u n t i n g  a t t e m p t s  o f  s t i m u l u s  m a l e .  I f  n o  m o u n t s
occurred within 5 min, the female was placed with a dif-
ferent stimulus male.
Test for masculine behaviour
In masculinization behavior tests, the female subject was
placed alone in her own cage to adapt for 15 min. Subse-
quently, an E2-primed C57BL/6 partner female was intro-
duced, and the number of mounts and intromission-like
behaviors shown by the female subject were recorded for
30 min. The occurrences of behaviors were counted once
the subject animal was separated by more than half the
body length from its partner. The behaviors were scored
b y  a n  o b s e r v e r  u n i n f o r m e d  o f  t h e  e x p e r i m e n t a l  t r e a t -
ments.
Testing urine preference
Eight to ten week-old female mice were injected daily for
3 days with 20 μg of 17β-estradiol [50]. The urines from
E2-primed female and male mice (n = 8) were collected by
holding the scruff of mouse during the 30 days of period
in order to get sufficient volume, which were pooled andPark et al. BMC Genetics 2010, 11:62
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immediately stored in aliquots at -80°C until use [52]. The
urine preference tests were normally carried out between
15:00 and 17:00. The tests were conducted in a clear
acrylic container (700 × 200 × 200 mm), which was
cleaned before testing, lined with a mix of clean and
home-cage beddings, and all of the subjects were habitu-
ated in a clear acrylic partition (230 × 180 × 180 mm)
placed in the center of the container for 20 min [53].
Olfactory stimuli soaked on 3 M paper disks (20 × 20
mm) with 100 μl of male or female urine were placed at
both ends of the container. The test was initiated by
removing the partition, and the times spent actively sniff-
ing the urine samples were recorded during a period of 5
min.
Immunocytochemistry for tyrosine hydroxylase
To determine tyrosine hydroxylase expression, each
mouse was anesthetized with an injection of Avertin
Anesthesia and killed by decapitation; their brains were
quickly removed and fixed in 4% paraformaldehyde in 0.1
M phosphate buffer at pH 7.4. After dehydration, paraffin
embedded sections (4 A ¯m) were rehydrated and micro-
waved in 10 mM citric acid buffer for 15 min, and washed
three times in TBS. Endogenous peroxidase was blocked
with 3% H2O2 for 10 min at room temperature. The sec-
tions were washed three more times in TBS and incu-
bated for 1 h at room temperature in TBS containing 0.1%
Tween 20 (TBST) with 3% bovine serum albumin. Each
slide was incubated overnight at 4°C with rabbit poly-
clonal antibodies to tyrosine hydroxylase (Abcam, Cam-
bridge, UK). Antibodies were diluted to working
concentrations (1:750 or 1:500) in TBST containing 3%
BSA. After 16 h at 4°C, the slides were washed three
times for 5 min each in TBST before incubation with
horseradish peroxidase-labeled goat anti-rabbit antibod-
ies (Zymed, South San Francisco, CA) for 1 h at room
temperature. The sections were washed three times for 5
min in TBST before application of an EnVision® Dual Link
HRP System (DakoCytomation, Carpinteria, CA). The
development of a brown-colored reaction was stopped by
rinsing them in TBST . T o quantify the number of TH-
positive neurons, all slides and images were coded so that
the investigator had no knowledge on genotypes of the
subjects, from which the immune-reactive cells were
counted using Olympus BX60 microscope.
2D-electrophoresis and binding studies
The fetal mouse sera containing AFP were obtained by
heart puncture of 25 each of wild-type and mutant
embryos at E16.5. The female mice were caged overnight
individually with males, and mating was verified by the
presence of a vaginal plug appeared in the following
morning (regarded as E0.5). Using 2D electrophoresis
and Matrix-assisted laser desorption/ionization - time-
of-flight mass spectrometer (MALDI-TOF-MS) analysis,
we detected two discriminantal isoforms of AFP. 2D gel
electrophoresis was performed using linear immobilized
pH gradient strips (GE Healthcare, Uppsala, Sweden)
with a pI range from 4-7. Following SDS-PAGE using 10%
gels, proteins were either visualized using Coomassie
blue staining or electrotransferred onto nitrocellulose
membranes before probing with anti-AFP antibody (goat
polyclonal, Santa Cruz Biotechnology). Differences in
fucosylation of AFP were assayed by crossed affinity
immunoelectrophoresis with biotin-conjugated Aleuria
aurantia lectin (Vector Laboratories, Burlingame, CA) or
biotin-conjugated  Ulex europaeus agglutinin I (Vector
Laboratories). Detection was performed using an ECL
system (Amersham Biosciences) according to the manu-
facturer's instructions. Spot intensities were analyzed
using the NIH Image J program.
The serum was incubated with 3[H]-estradiol (Perki-
nElmer Life and Analytical Sciences, Boston, MA) in a
concentration of 10-9 M to 2 × 10-6 M in 20 mM Hepes pH
7.4, 50 mM NaCl and 20% glycerol (HNG buffer) for 1 h
at room temperature [18,54]. Nonspecifically bound
counts were subtracted from the total counts to yield spe-
cifically bound counts. A bound steroid was separated
from a free one using dextran-coated charcoal (DCC,
Sigma). Measurements were done in duplicate, and each
experiment was repeated three times. The association
constant (Ka) and maximal binding capacity (Bmax) were
estimated by the Scatchard plot analysis.
Gene expression analysis
Total RNAs were isolated from mouse embryos by
homogenizing with the TRI reagent (the manufacturer's
protocol, Molecular research center). Prior to RT-PCR,
aliquots of 4 μg of total RNA extracted from complete
embryos were used as template for reverse transcriptase
with oligo-dT Primers. Reverse transcription was carried
out with RNase H- Superscript II reverse transcriptase
(Invitrogen). Real Time PCR reactions (20 μl) contained
10 μl of iQ SYBR Green Supermix (Biorad), 1 μl cDNA
and primers (PrimerBank ID, 31982513a1; forward, 5'-
CTTCCCTCATCCTCCTGCTAC-3'; reverse, 5'-
ACAAACTGGGTAAAGGTGATGG-3'). For quantita-
t i v e  PC R,  S Y B R  fl u o r e s c e n c e  w a s  u s e d  t o  g e n e r a t e  C t
value that was normalized to obtain absolute values using
G A P D H  a s  a n  i n t e r n a l  s t a n d a r d .  A l l  a s s a y s  w e r e  c o n -
ducted in triplicates.
Statistical analysis
Statistical comparisons were done using one-way analysis
of variance (ANOVA) or repeated measures ANOVA, fol-
lowed by Fisher's least protected significant difference
test.Park et al. BMC Genetics 2010, 11:62
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